Inventor · disambiguated record
Suzanne Elaine Keeling
Also filed as: KEELING SUZANNE E · KEELING SUZANNE ELAINE
21 granted patents·10 pending applications·241 citations·filing 1997–2020
95Inventor score
Files withGLAXO GROUP LTD13HAMBLIN JULIE NICOLE9SMITHKLINE BEECHAM CORP3GLAXOSMITHKLINE IP DEV LTD2ANCLIFF RACHAEL A1
Top patents by PatentIndex Score
31 records- 0197US8586583B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Nov 19, 2013·52 cites·7 claims
- 0290US10383879B2CompoundsGLAXO GROUP LTD·Filed 2019·Granted Aug 20, 2019·4 cites·8 claims
- 0389US9353098B2Polymorphs and saltsGLAXO GROUP LTD·Filed 2015·Granted May 31, 2016·4 cites·3 claims
- 0489US8609657B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Dec 17, 2013·6 cites·11 claims
- 0588US9326987B2Indazole derivatives for use in the treatment of influenza virus infectionHAMBLIN JULIE NICOLE·Filed 2011·Granted May 3, 2016·5 cites·3 claims
- 0688US8575162B2CompoundsHAMBLIN JULIE NICOLE·Filed 2010·Granted Nov 5, 2013·6 cites·7 claims
- 0787US8586590B2CompoundsHAMBLIN JULIE NICOLE·Filed 2012·Granted Nov 19, 2013·5 cites·11 claims
- 0887US8580797B2CompoundsHAMBLIN JULIE NICOLE·Filed 2010·Granted Nov 12, 2013·5 cites·8 claims
- 0986US9102668B2Polymorphs and saltsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Aug 11, 2015·3 cites·4 claims
- 1085US6426337B12-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivativesSMITHKLINE BEECHAM CORP·Filed 1997·Granted Jul 30, 2002·67 cites·50 claims
- 1184US6528494B22-(purin-9-yl)-tetrahydrofuran-3,4-diol derivativesFiled 2001·Granted Mar 4, 2003·23 cites·2 claims
- 1280US8735390B2Polymorphs and saltsHAMBLIN JULIE NICOLE·Filed 2011·Granted May 27, 2014·5 cites·3 claims
- 1376US8993576B26-(1H-indol-4-yl)-4-(5-{[4-1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole hemi succinate salt, polymorphs and pharmaceutical compositions thereofHAMBLIN JULIE NICOLE·Filed 2011·Granted Mar 31, 2015·3 cites·4 claims
- 1476US7101882B2Morpholin-acetamide derivatives for the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2001·Granted Sep 5, 2006·8 cites·25 claims
- 1574US10624898B2CompoundsGLAXO GROUP LTD·Filed 2019·Granted Apr 21, 2020·0 cites·8 claims
- 1672US10946025B2CompoundsGLAXO GROUP LTD·Filed 2020·Granted Mar 16, 2021·0 cites·6 claims
- 1772US8524751B24-oxadiazol-2-YL-indazoles as inhibitors of P13 kinasesHAMBLIN JULIE NICOLE·Filed 2010·Granted Sep 3, 2013·3 cites·9 claims
- 1869US7622464B2Morpholinyl-urea derivatives for use in the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2003·Granted Nov 24, 2009·6 cites·12 claims
- 1969US2018325911A1Novel compoundsGLAXO GROUP LTD·Filed 2018·Application pending·0 cites
- 2067US2014080830A1Novel CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2013·Application pending·0 cites
- 2166US2017157136A1Novel compoundsGLAXO GROUP LTD·Filed 2017·Application pending·0 cites
- 2265US6534486B12-(purin-9-yl)-Tetrahydrofuran-3,4-diol derivativesSMITHKLINE BEECHAM CORP·Filed 1999·Granted Mar 18, 2003·24 cites·16 claims
- 2364US2017015656A1Novel compoundsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 2463US7157457B2Compounds useful in the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2001·Granted Jan 2, 2007·2 cites·6 claims
- 2563US2009163495A1Morpholin-acetamide derivatives for the treatment of inflammatory diseasesGLAXO GROUP LTD·Filed 2009·Application pending·0 cites
- 2661US2015328226A1Novel CompoundsGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 2756US2016237073A1Novel Polymorphs and SaltsGLAXO GROUP LTD·Filed 2016·Application pending·0 cites
- 2851US2008255186A1Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 InhibitorCHRISTENSEN SIEGFRIED BENJAMIN·Filed 2006·Application pending·0 cites
- 2951US2009131431A1Pyrazolo[3,4-b]pyridine compounds, and their use as a PDE4 inhibitorsEDLIN CHRISTOPHER DAVID·Filed 2006·Application pending·0 cites
- 3050US6495528B12-(Purin -9-yl)-tetrahydrofuran-3,4-diol derivativesSMITHKLINE BEECHAM CORP·Filed 1999·Granted Dec 17, 2002·10 cites·26 claims
- 3138US2006058299A1N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditionsANCLIFF RACHAEL A·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →